These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4074445)

  • 41. Nitrate tolerance: comparison of nicorandil, isosorbide dinitrate, and nitroglycerin in anesthetized dogs.
    Sakai K; Kuromaru O
    J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S17-24. PubMed ID: 2447420
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutaneous pharmacodynamics of transdermally delivered isosorbide dinitrate.
    Hori M; Ohtsuka S; Sunami M; Guy RH; Maibach HI
    Pharm Res; 1990 Dec; 7(12):1298-301. PubMed ID: 2095569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differences in the production of methemoglobin during high-dose treatment with isosorbide dinitrate or isosorbide 5-mononitrate.
    Schneider W; Stahl B; Kaltenbach M; Bussmann WD
    Arzneimittelforschung; 1984; 34(12):1779-82. PubMed ID: 6543314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bioavailability and bioequivalence of organic nitrates. Isosorbide dinitrate--a study of sustained-release preparations].
    Scheidel B; Blume H; Stenzhorn G; Siewert M; Babej-Dölle RM
    Arzneimittelforschung; 1991 Mar; 41(3):212-8. PubMed ID: 1867657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pharmacodynamic effects of the sustained-release tablet of isosorbide dinitrate and its bioavailability in conscious dogs (author's transl)].
    Kogi K; Chida S; Kimura T; Saito T
    Nihon Yakurigaku Zasshi; 1980 Mar; 76(2):99-107. PubMed ID: 7399370
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lack of oxidative stress during sustained therapy with isosorbide dinitrate and pentaerythrityl tetranitrate in healthy humans: a randomized, double-blind crossover study.
    Keimer R; Stutzer FK; Tsikas D; Troost R; Gutzki FM; Frölich JC
    J Cardiovasc Pharmacol; 2003 Feb; 41(2):284-92. PubMed ID: 12548090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical evaluation of isosorbide dinitrate (ISDN) spray: a study on the plasma concentrations of ISDN and on its hemodynamic effects using three administration routes].
    Kinoshita R; Ishida K; Sendaya K; Miyagawa A; Oda S; Taniguchi K; Honda N
    Masui; 1990 Dec; 39(12):1660-3. PubMed ID: 2098594
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow-release isosorbide dinitrate.
    Weidemann H; Schuon J; Schober B
    Z Kardiol; 1983; 72 Suppl 3():229-32. PubMed ID: 6666226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemodynamic and humoral effects at rest and after head-up tilt tests during 24-hour infusion of a new nitrate ester, ITF 296, compared with ISDN and placebo in healthy volunteers: a double-blind, randomized, within-subject study.
    Sardina M; Warrington SJ; Boyce M; Johnston A; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S80-90. PubMed ID: 8839231
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Equal anti-ischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, double-blind and crossover study.
    Silber S; Vogler A; Theisen K
    Z Kardiol; 1986; 75 Suppl 3():100-5. PubMed ID: 3541414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate.
    Schaumann W
    Int J Clin Pharmacol Ther Toxicol; 1989 Sep; 27(9):445-53. PubMed ID: 2681004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dose-dependent serum concentration of ISDN and its metabolites following administration of ISDN-retard. Studies under steady-state conditions].
    Loew D; Deuster U; Burkhardt H; Rietbrock N
    Dtsch Med Wochenschr; 1986 Nov; 111(48):1834-7. PubMed ID: 3536397
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between isosorbide dinitrate plasma levels and coronary vasodilation after chewing capsules.
    Jost S; Rafflenbeul W; Knop I; Bossaller C; Reil GH; Gulba D; Hecker H; Lichtlen P
    Z Kardiol; 1989; 78 Suppl 2():106-8; discussion 115-7. PubMed ID: 2588759
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of isosorbide dinitrate concentration on its skin permeability from adhesive matrix devices.
    Hatanaka T; Oguchi M; Sugibayashi K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1991 Jul; 39(7):1802-5. PubMed ID: 1777935
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
    Kośmicki M; Sadowski Z; Szwed H; Kowalik I
    Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism of isosorbide dinitrate in the isolated perfused rabbit lung.
    Mayer PR; Lubawy WC; McNamara PJ; Kostenbauder HB
    J Pharm Sci; 1983 Jul; 72(7):785-9. PubMed ID: 6886987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral administration of isosorbide dinitrate inhibits arterial thrombosis in rats.
    Plotkine M; Allix M; Guillou J; Boulu R
    Eur J Pharmacol; 1991 Aug; 201(1):115-6. PubMed ID: 1794412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electron beam irradiation: a novel technology for the development of transdermal system of isosorbide dinitrate.
    Kotiyan PN; Vavia PR; Bhardwaj YK; Sabarwal S; Majali AB
    Int J Pharm; 2004 Feb; 270(1-2):47-54. PubMed ID: 14726121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A study into the mucosal absorption of isosorbide dinitrate at different intraoral sites.
    Pimlott SJ; Addy M
    Oral Surg Oral Med Oral Pathol; 1985 Feb; 59(2):145-8. PubMed ID: 3856798
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Efficacy of the Transdermal Isosorbide Dinitrate Patch in Patients With Chronic Limb-Threatening Ischemia.
    Matsui A; Murakami M; Hata S; Terabe Y; Nakabayashi K; Kaneko N; Tanaka K; Ando H
    Int J Low Extrem Wounds; 2022 Dec; 21(4):477-482. PubMed ID: 32962459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.